Cervical cancer

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study
A prospective cohort study to identify biomarkers predicting the regression of grade 2 Cervical Intraepithelial Neoplasia. Study protocol
Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results
Changes in cervical cancer incidence following the introduction of organized screening in Italy
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process.
Esito clinico delle lesioni CIN2 trattate
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation from the Multisociety Italian Guidelines for cervical cancer prevention
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project
Indicators for monitoring screening programs with primary hpv test
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial
Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: a Retrospective Monoinstitutional Cohort Study
Nuove Tecnologie per il cancro della Cervice 2 (NTCC2): disegno dello studio e andamento del reclutamento
Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial

Pagina 1 di 2

Inizio
Indietro
1
2
Avanti
Fine

Questo sito web utilizza cookies per fornirti una migliore esperienza di navigazione. Scopri di più.